Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages

Silvia Franchi1, Sarah Moretti, Mara Castelli

  • 1Dipartimento di Farmacologia Chemioterapia e Tossicologia medica, Università degli Studi di Milano, Via Vanvitelli 32, 20129 Milano, Italy.

Insights

Morphine suppresses immune responses by decreasing Toll-like receptor 4 (TLR4) in macrophages. This occurs via mu-opioid receptor (MOR) activation, revealing a new pathway for opioid-induced immunosuppression.

Area of Science:

  • Immunology
  • Pharmacology
  • Neuroscience

Background:

  • Opioids modulate innate and adaptive immunity.
  • Morphine affects macrophage pro-inflammatory cytokine production via NF-kB.
  • Toll-like receptors (TLRs), particularly TLR4, are critical for pathogen recognition and NF-kB activation.

Purpose of the Study:

  • To investigate the impact of morphine on Toll-like receptor 4 (TLR4) expression and function in murine macrophages.
  • To elucidate the role of the mu-opioid receptor (MOR) in morphine's effect on TLR4.
  • To identify the signaling pathway involved in MOR-mediated regulation of TLR4.

Main Methods:

  • Morphine treatment of RAW 264.7 cells and murine models.
  • Assessment of TLR4 mRNA and protein levels.
  • Administration of MOR antagonist Naltrexone and MOR-specific agonist DAMGO.
  • Experiments using MOR knockout (KO) mice.
  • Pertussis toxin (PTX) treatment to assess G(i) protein involvement.

Main Results:

  • Morphine decreased both mRNA and protein levels of TLR4 in macrophages.
  • Naltrexone increased TLR4 levels, suggesting endogenous opioid system regulation.
  • Co-administration of morphine and Naltrexone abolished the effects.
  • MOR activation was confirmed as the mechanism for morphine's effect on TLR4.
  • The effect was blocked by PTX, indicating G(i) protein signaling.

Conclusions:

  • Morphine directly impacts pathogen recognition by reducing TLR4 expression in macrophages.
  • Mu-opioid receptor activation is central to this immunosuppressive effect.
  • This study reveals a novel mechanism linking MOR activation to TLR4 regulation, contributing to opioid-induced peripheral immunosuppression.